Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)

Clinical trial NCT00169585 · COMPLETED

Trial details

NCT number: NCT00169585
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostatic Hyperplasia Prostatitis

Start date: 2005-03-01
Primary completion: 2007-04-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.